Ville Paavilainen

View Scopus Profile

Phone+358504484600, +358294159929
Emailville.paavilainen@helsinki.fi

PL 65 (Viikinkaari 1)
00014
Finland
Viikinkaari 5, Biocenter 2
00790 Helsinki
Finland

Research activity per year

If you made any changes in Pure these will be visible here soon.

External positions

Post-doctoral Researcher, University of California San Francisco

2008 → 2014

Fields of Science

1182 Biochemistry, cell and molecular biology

24 Article
4 Review Article
1 Chapter
1 Doctoral Thesis
More
- 1 Working paper

Carbonic anhydrase seven bundles filamentous actin and regulates dendritic spine morphology and density
Bertling, E., Blaesse, P., Seja, P., Kremneva, E., Gateva, G., Virtanen, M. A., Summanen, M., Spoljaric, I., Uvarov, P., Blaesse, M., Paavilainen, V. O., Vutskits, L., Kaila, K., Hotulainen, P. & Ruusuvuori, E., 7 Apr 2021, In: EMBO Reports. 22, 4, 17 p., 50145.
Research output: Contribution to journal › Article › Scientific › peer-review

Open Access
File
Targeting of HER/ErbB family proteins using broad spectrum Sec61 inhibitors coibamide A and apratoxin A
Kazemi, S., Kawaguchi, S., Badr, C. E., Mattos, D. R., Ruiz-Saenz, A., Serrill, J. D., Moasser, M. M., Dolan, B. P., Paavilainen, V. O., Oishi, S., McPhail, K. L. & Ishmael, J. E., Jan 2021, In: Biochemical Pharmacology. 183, 16 p., 114317.
Research output: Contribution to journal › Article › Scientific › peer-review

Open Access
File
A novel phylogenetic analysis and machine learning predict pathogenicity of human mtDNA variants
Dunn, C., Akpinar, A., Carlson, P. & Paavilainen, V., 10 Oct 2020, bioRxiv.
Research output: Working paper › Scientific
Coibamide A Targets Sec61 to Prevent Biogenesis of Secretory and Membrane Proteins
Tranter, D., Paatero, A. O., Kawaguchi, S., Kazemi, S., Serrill, J. D., Kellosalo, J., Vogel, W. K., Richter, U., Mattos, D. R., Wan, X., Thornburg, C. C., Oishi, S., McPhail, K. L., Ishmael, J. E. & Paavilainen, V. O., 21 Aug 2020, In: ACS Chemical Biology. 15, 8, p. 2125-2136 12 p.
Research output: Contribution to journal › Article › Scientific › peer-review

Open Access
File
Kendomycin Cytotoxicity against Bacterial, Fungal, and Mammalian Cells Is Due to Cation Chelation
Tranter, D., Filipuzzi, I., Lochmann, T., Knapp, B., Kellosalo, J., Estoppey, D., Pistorius, D., Meissner, A., Paavilainen, V. O. & Hoepfner, D., 24 Apr 2020, In: Journal of Natural Products. 83, 4, p. 965-971 7 p.
Research output: Contribution to journal › Article › Scientific › peer-review

Open Access
File

1 Active

Inhibitors of SARS-Coronavirus-2 infection
Vapalahti, O., Huiskonen, J., Paavilainen, V., Saavalainen, P., Saviranta, P. & Kallioniemi, O.
Academy of Finland
01/07/2020 → 31/12/2022
Project: Research project

7 Member of doctoral thesis committee / follow-up group
5 Invited talk
3 Academic visit at UH
2 Organisation and participation in conferences, workshops, courses, seminars
More
- 1 Supervisor or co-supervisor of doctoral thesis
- 1 Supervision of other thesis (Master's, Licentiate)

Keynote Lecture at 1st Drug Discovery and Development Conference -Pakistan
Ville Paavilainen (Speaker)
3 Jan 2018
Activity: Talk or presentation types › Invited talk
Talk at EMBO Proteostasis Meeting -Ericeira, Portugal
Ville Paavilainen (Speaker)
30 Nov 2017
Activity: Talk or presentation types › Invited talk
Pieta Mattila
Ville Paavilainen (Host)
25 Jan 2016
Activity: Hosting a visitor types › Academic visit at UH
Member of doctoral thesis committee Kah Ying Ng
Ville Paavilainen (Supervisor)
2016
Activity: Examination types › Member of doctoral thesis committee / follow-up group
Member of doctoral thesis committee Liang Wang
Ville Paavilainen (Supervisor)
2016
Activity: Examination types › Member of doctoral thesis committee / follow-up group

Finnish drug lead molecule shows promise in targeting the new coronavirus
Olli Vapalahti & Ville Paavilainen
15/07/2020
1 item of Media coverage
Press/Media: Press / Media
Ongoing research shows potential of anti-coronavirus drug
Ville Paavilainen
07/05/2020
1 item of Media coverage
Press/Media: Press / Media
-UNIVERSITY OF HELSINKI: A drug lead molecule studied by Viikki Biochemists may help in the fight against COVID-19
Olli Vapalahti & Ville Paavilainen
07/05/2020
1 item of Media coverage
Press/Media: Press / Media
Drug lead molecule may help to fight against coronavirus
Ville Paavilainen
06/05/2020
1 item of Media coverage
Press/Media: Press / Media
A drug lead molecule studied by Viikki Biochemists may help in the fight against COVID-19
Olli Vapalahti & Ville Paavilainen
06/05/2020
1 item of Media coverage
Press/Media: Press / Media

Ville Paavilainen

Personal profile

External positions

Fields of Science

International and National Collaboration

Dive into details

Carbonic anhydrase seven bundles filamentous actin and regulates dendritic spine morphology and density

Targeting of HER/ErbB family proteins using broad spectrum Sec61 inhibitors coibamide A and apratoxin A

A novel phylogenetic analysis and machine learning predict pathogenicity of human mtDNA variants

Coibamide A Targets Sec61 to Prevent Biogenesis of Secretory and Membrane Proteins

Kendomycin Cytotoxicity against Bacterial, Fungal, and Mammalian Cells Is Due to Cation Chelation

Inhibitors of SARS-Coronavirus-2 infection

Keynote Lecture at 1st Drug Discovery and Development Conference -Pakistan

Talk at EMBO Proteostasis Meeting -Ericeira, Portugal

Pieta Mattila

Member of doctoral thesis committee Kah Ying Ng

Member of doctoral thesis committee Liang Wang

Finnish drug lead molecule shows promise in targeting the new coronavirus

Ongoing research shows potential of anti-coronavirus drug

-UNIVERSITY OF HELSINKI: A drug lead molecule studied by Viikki Biochemists may help in the fight against COVID-19

Drug lead molecule may help to fight against coronavirus

A drug lead molecule studied by Viikki Biochemists may help in the fight against COVID-19

Ville Paavilainen

Personal profile

External positions

Fields of Science

International and National Collaboration

Publications

Projects

Activities

Press / Media